Although SCC antigen is typically considered a representative tumor marker for cervical cancer, other markers, such as CA19–9 and CA125, also play an important role in the diagnosis of gynecological tumors, particularly ovarian cancer (14, 15). This evidence concerns the gene MUC16 and neoplasm.